Intravenous and regional paclitaxel formulations

Rajendra Pawar; Ariella Shikanov; Boris Vaisman; Abraham J. Domb

doi:10.2174/0929867043455981

Intravenous and regional paclitaxel formulations

Rajendra Pawar
, Ariella Shikanov
, Boris Vaisman
, Abraham J. Domb

Hebrew University of Jerusalem

Research output: Contribution to journal › Review article › peer-review

18 Scopus citations

Abstract

Paclitaxel has been proven to be effective against different types of cancer. A delivery system loaded with paclitaxel at tumor site should provide a high local concentration of the drug detrimental to malignant cells, which prevents the re-growth and metastasis of tumor. In this review, paclitaxel formulations for systemic and for intratumoral administration are discussed.

Original language	English
Pages (from-to)	397-402
Number of pages	6
Journal	Current Medicinal Chemistry
Volume	11
Issue number	4
DOIs	https://doi.org/10.2174/0929867043455981
State	Published - Feb 2004
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Delivery systems
Formulations
Intratumoral delivery
Paclitaxel
Polymers

Access to Document

10.2174/0929867043455981

Cite this

@article{cd913c7eddf348d48f58fb3730a9c0a9,

title = "Intravenous and regional paclitaxel formulations",

abstract = "Paclitaxel has been proven to be effective against different types of cancer. A delivery system loaded with paclitaxel at tumor site should provide a high local concentration of the drug detrimental to malignant cells, which prevents the re-growth and metastasis of tumor. In this review, paclitaxel formulations for systemic and for intratumoral administration are discussed.",

keywords = "Delivery systems, Formulations, Intratumoral delivery, Paclitaxel, Polymers",

author = "Rajendra Pawar and Ariella Shikanov and Boris Vaisman and Domb, \{Abraham J.\}",

year = "2004",

month = feb,

doi = "10.2174/0929867043455981",

language = "אנגלית",

volume = "11",

pages = "397--402",

journal = "Current Medicinal Chemistry",

issn = "0929-8673",

publisher = "Bentham Science Publishers",

number = "4",

}

TY - JOUR

T1 - Intravenous and regional paclitaxel formulations

AU - Pawar, Rajendra

AU - Shikanov, Ariella

AU - Vaisman, Boris

AU - Domb, Abraham J.

PY - 2004/2

Y1 - 2004/2

N2 - Paclitaxel has been proven to be effective against different types of cancer. A delivery system loaded with paclitaxel at tumor site should provide a high local concentration of the drug detrimental to malignant cells, which prevents the re-growth and metastasis of tumor. In this review, paclitaxel formulations for systemic and for intratumoral administration are discussed.

AB - Paclitaxel has been proven to be effective against different types of cancer. A delivery system loaded with paclitaxel at tumor site should provide a high local concentration of the drug detrimental to malignant cells, which prevents the re-growth and metastasis of tumor. In this review, paclitaxel formulations for systemic and for intratumoral administration are discussed.

KW - Delivery systems

KW - Formulations

KW - Intratumoral delivery

KW - Paclitaxel

KW - Polymers

UR - https://www.scopus.com/pages/publications/1442350447

U2 - 10.2174/0929867043455981

DO - 10.2174/0929867043455981

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 14965220

AN - SCOPUS:1442350447

SN - 0929-8673

VL - 11

SP - 397

EP - 402

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

IS - 4

ER -

Intravenous and regional paclitaxel formulations

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this